S

Salarius Pharmaceuticals
D

SLRX

1.34000
USD
-0.01
(-0.74%)
مغلق
حجم التداول
1,815
الربح لكل سهم
-188
العائد الربحي
-
P/E
-0
حجم السوق
2,121,980
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    ABBV
    ABBV
    1.200
    (0.60%)
    202.140 USD
    B
    BHC
    0.13500
    (1.88%)
    7.31000 USD
    BMY
    BMY
    0.050
    (0.09%)
    55.840 USD
    GSK
    GSK
    -0.320
    (-0.87%)
    36.650 USD
    JNJ
    JNJ
    2.680
    (1.68%)
    162.370 USD
    MRK
    MRK
    1.820
    (2.08%)
    89.500 USD
    O
    OPK
    0.00500
    (0.30%)
    1.67500 USD
    PFE
    PFE
    0.405
    (1.56%)
    26.305 USD
    P
    PSTV
    -0.09000
    (-6.98%)
    1.20000 USD
    Z
    ZYME
    0.380
    (2.71%)
    14.380 USD
    المزيد
الأخبار
المقالات

العنوان: Salarius Pharmaceuticals Inc.

القطاع: Healthcare
الصناعة: Biotechnology
Salarius Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing effective treatments for cancers with high, unmet medical needs. The company has focused on two classes of drugs that address gene dysregulation: targeted protein inhibitors and targeted protein degradation. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader.